eCite Digital Repository
Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms
Citation
Dong, Y and Bui, LT and Odorico, DM and Tan, OL and Myers, SA and Samaratunga, H and Gardiner, RA and Clements, JA, Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms, Endocrine - Related Cancer, 12 pp. 875-889. ISSN 1351-0088 (2005) [Refereed Article]
Copyright Statement
© 2005 Society for Endocrinology
Abstract
The prostate-specific antigen-related serine protease gene, kallikrein 4 (KLK4), is expressed in
the prostate and, more importantly, overexpressed in prostate cancer. Several KLK4 mRNA
splice variants have been reported, but it is still not clear which of these is most relevant to
prostate cancer. Here we report that, in addition to the full-length KLK4 (KLK4-254) transcript,
the exon 1 deleted KLK4 transcripts, in particular, the 50
-truncated KLK4-205 transcript, is
expressed in prostate cancer. Using V5/His6 and green fluorescent protein (GFP) carboxy terminal
tagged expression constructs and immunocytochemical approaches, we found that hK4-254 is
cytoplasmically localized, while the N-terminal truncated hK4-205 is in the nucleus of transfected
PC-3 prostate cancer cells. At the protein level, using anti-hK4 peptide antibodies specific to
different regions of hK4-254 (N-terminal and C-terminal), we also demonstrated that endogenous
hK4-254 (detected with the N-terminal antibody) is more intensely stained in malignant cells than in
benign prostate cells, and is secreted into seminal fluid. In contrast, for the endogenous nuclearlocalized
N-terminal truncated hK4-205 form, there was less difference in staining intensity between
benign and cancer glands. Thus, KLK4-254/hK4-254 may have utility as an immunohistochemical
marker for prostate cancer. Our studies also indicate that the expression levels of the truncated
KLK4 transcripts, but not KLK4-254, are regulated by androgens in LNCaP cells. Thus, these data
demonstrate that there are two major isoforms of hK4 (KLK4-254/hK4-254 and KLK4-205/hK4-205)
expressed in prostate cancer with different regulatory and expression profiles that imply both
secreted and novel nuclear roles
Item Details
Item Type: | Refereed Article |
---|---|
Keywords: | Kallikreins |
Research Division: | Biological Sciences |
Research Group: | Biochemistry and cell biology |
Research Field: | Enzymes |
Objective Division: | Health |
Objective Group: | Clinical health |
Objective Field: | Clinical health not elsewhere classified |
UTAS Author: | Myers, SA (Dr Stephen Myers) |
ID Code: | 100911 |
Year Published: | 2005 |
Web of Science® Times Cited: | 50 |
Deposited By: | Health Sciences B |
Deposited On: | 2015-06-03 |
Last Modified: | 2015-09-15 |
Downloads: | 0 |
Repository Staff Only: item control page